Prevention of cardiovascular events in early menopause

A possible role for hormone replacement therapy

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Heart disease is a major cause of illness and death in women. It is well known that there is an increase in cardiovascular disease and cardiovascular risk factors after the menopause, but it is still unclear whether the change in risk factors after the menopause is only related to the aging process or is principally due to estrogen deprivation. Observational studies suggest a protective role for estrogens, whereas recent randomized controlled trials report a negative effect of oral estrogens on primary and secondary prevention of cardiovascular events. The role of inflammation in the process of atherogenesis and in determining the cardiovascular disease risk in postmenopausal women has been focused only recently as well as the role of the estrogen receptor system in different tissues and the role of genetic susceptibility to adverse events during estrogen therapy. The objective of this work was to review the current understanding of the relationships between cardiovascular disease risk factors and hormonal age-related changes in postmenopausal women and particularly in early and surgical postmenopausal women, for a more appropriate evaluation of the expected effects of therapy with exogenous estrogens in a specific sample of the large population of postmenopausal women.

Original languageEnglish
Pages (from-to)140-146
Number of pages7
JournalInternational Journal of Cardiology
Volume130
Issue number2
DOIs
Publication statusPublished - Nov 12 2008

Fingerprint

Hormone Replacement Therapy
Menopause
Estrogens
Cardiovascular Diseases
Primary Prevention
Genetic Predisposition to Disease
Secondary Prevention
Estrogen Receptors
Observational Studies
Cause of Death
Heart Diseases
Atherosclerosis
Randomized Controlled Trials
Inflammation
Therapeutics
Population

Keywords

  • Cardiovascular prevention
  • Early menopause
  • Estrogens
  • Hormone replacement therapy
  • Menopause
  • Ovariectomy
  • Surgical menopause

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Prevention of cardiovascular events in early menopause : A possible role for hormone replacement therapy. / Antonicelli, Roberto; Olivieri, Fabiola; Morichi, Valeria; Urbani, Elisa; Mais, Valerio.

In: International Journal of Cardiology, Vol. 130, No. 2, 12.11.2008, p. 140-146.

Research output: Contribution to journalArticle

@article{c88d3f8229034e50b09401f977c2f975,
title = "Prevention of cardiovascular events in early menopause: A possible role for hormone replacement therapy",
abstract = "Heart disease is a major cause of illness and death in women. It is well known that there is an increase in cardiovascular disease and cardiovascular risk factors after the menopause, but it is still unclear whether the change in risk factors after the menopause is only related to the aging process or is principally due to estrogen deprivation. Observational studies suggest a protective role for estrogens, whereas recent randomized controlled trials report a negative effect of oral estrogens on primary and secondary prevention of cardiovascular events. The role of inflammation in the process of atherogenesis and in determining the cardiovascular disease risk in postmenopausal women has been focused only recently as well as the role of the estrogen receptor system in different tissues and the role of genetic susceptibility to adverse events during estrogen therapy. The objective of this work was to review the current understanding of the relationships between cardiovascular disease risk factors and hormonal age-related changes in postmenopausal women and particularly in early and surgical postmenopausal women, for a more appropriate evaluation of the expected effects of therapy with exogenous estrogens in a specific sample of the large population of postmenopausal women.",
keywords = "Cardiovascular prevention, Early menopause, Estrogens, Hormone replacement therapy, Menopause, Ovariectomy, Surgical menopause",
author = "Roberto Antonicelli and Fabiola Olivieri and Valeria Morichi and Elisa Urbani and Valerio Mais",
year = "2008",
month = "11",
day = "12",
doi = "10.1016/j.ijcard.2008.03.051",
language = "English",
volume = "130",
pages = "140--146",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Prevention of cardiovascular events in early menopause

T2 - A possible role for hormone replacement therapy

AU - Antonicelli, Roberto

AU - Olivieri, Fabiola

AU - Morichi, Valeria

AU - Urbani, Elisa

AU - Mais, Valerio

PY - 2008/11/12

Y1 - 2008/11/12

N2 - Heart disease is a major cause of illness and death in women. It is well known that there is an increase in cardiovascular disease and cardiovascular risk factors after the menopause, but it is still unclear whether the change in risk factors after the menopause is only related to the aging process or is principally due to estrogen deprivation. Observational studies suggest a protective role for estrogens, whereas recent randomized controlled trials report a negative effect of oral estrogens on primary and secondary prevention of cardiovascular events. The role of inflammation in the process of atherogenesis and in determining the cardiovascular disease risk in postmenopausal women has been focused only recently as well as the role of the estrogen receptor system in different tissues and the role of genetic susceptibility to adverse events during estrogen therapy. The objective of this work was to review the current understanding of the relationships between cardiovascular disease risk factors and hormonal age-related changes in postmenopausal women and particularly in early and surgical postmenopausal women, for a more appropriate evaluation of the expected effects of therapy with exogenous estrogens in a specific sample of the large population of postmenopausal women.

AB - Heart disease is a major cause of illness and death in women. It is well known that there is an increase in cardiovascular disease and cardiovascular risk factors after the menopause, but it is still unclear whether the change in risk factors after the menopause is only related to the aging process or is principally due to estrogen deprivation. Observational studies suggest a protective role for estrogens, whereas recent randomized controlled trials report a negative effect of oral estrogens on primary and secondary prevention of cardiovascular events. The role of inflammation in the process of atherogenesis and in determining the cardiovascular disease risk in postmenopausal women has been focused only recently as well as the role of the estrogen receptor system in different tissues and the role of genetic susceptibility to adverse events during estrogen therapy. The objective of this work was to review the current understanding of the relationships between cardiovascular disease risk factors and hormonal age-related changes in postmenopausal women and particularly in early and surgical postmenopausal women, for a more appropriate evaluation of the expected effects of therapy with exogenous estrogens in a specific sample of the large population of postmenopausal women.

KW - Cardiovascular prevention

KW - Early menopause

KW - Estrogens

KW - Hormone replacement therapy

KW - Menopause

KW - Ovariectomy

KW - Surgical menopause

UR - http://www.scopus.com/inward/record.url?scp=54949088997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54949088997&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2008.03.051

DO - 10.1016/j.ijcard.2008.03.051

M3 - Article

VL - 130

SP - 140

EP - 146

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 2

ER -